Optiver Holding
PTCT icon

Optiver Holding’s PTC Therapeutics PTCT Stock Holding History

Optiver Holding’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.7K Buy
+389
New +$28.1K ﹤0.01% 1325
2025
Q4 		– Sell
-507
Closed -$31.1K – 2875
2025
Q3 		$31.1K Buy
507
+249
+97% +$13K ﹤0.01% 867
2025
Q2 		$12.6K Buy
258
+126
+95% +$5.98K ﹤0.01% 943
2025
Q1 		$6.73K Buy
+132
New +$6.59K ﹤0.01% 1014

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Optiver Holding's PTCT Position: Q2 2026 in Review

Optiver Holding opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 389 shares worth $31.7K. The stake represents ﹤0.01% of the portfolio and ranks #1325 among its holdings. This is a return to the name: Optiver Holding previously reported a position in PTCT as recently as Q3 2025.

Optiver Holding first reported a position in PTCT in Q1 2025 and has held it in 4 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Optiver Holding held 389 shares of PTC Therapeutics worth $31.7K as of Q2 2026.
  • PTC Therapeutics was a new Optiver Holding position in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1325 holding.
  • Optiver Holding first reported a position in PTC Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.